Sustaining Independent Careers in Vision Research: Demographics and Success in Second R01 Attainment Among Clinician-Scientists from 1985 to 2019
- PMID: 33262906
- PMCID: PMC7691794
- DOI: 10.1167/tvst.9.12.32
Sustaining Independent Careers in Vision Research: Demographics and Success in Second R01 Attainment Among Clinician-Scientists from 1985 to 2019
Abstract
Purpose: To evaluate the success of ophthalmology and optometry clinician-scientists in obtaining a second R01 (renewal or new) and factors associated with this success, including gender, clinical specialty, degree, institution, and bench versus non-bench research.
Methods: First-time National Eye Institute (NEI) R01 awardee data from 1985 to 2014 (N = 234) were analyzed to calculate second R01 success rates. Only R01 awards to ophthalmology or optometry clinician-scientists were included. Demographic data were obtained from clinicians with first-time NEI R01 funding spanning from 1962 to 2019 (N = 386). We obtained information regarding time span of the first R01, year of second R01, institution, and project title on the National Institutes of Health (NIH) Research Portfolio Online Reporting Tool, Expenditures and Results (RePORTER) database, and additional measures of gender, clinical specialty, and degree by performing Internet searches.
Results: Overall, from 1985 to 2014, 62.8% of ophthalmology or optometry clinician-scientists were awarded a second R01; at 5 years after receipt of the first R01 (the typical length of an R01), only 3.9% received their second R01. None of the factors examined (temporal cohort, gender, clinical specialty, degree, institution, or bench vs. non-bench research) was significantly associated with successful attainment of a second R01.
Conclusions: We found an overall success rate of 62.8% for receiving a second R01, but 5 years after the first R01 an attainment rate for a second R01 of only ∼4%.
Translational relevance: Our study provides insight on significant leaks in the clinician-scientist pipeline and raises questions of how stakeholders should support this important group of individuals at the intersection of clinical medicine and biomedical research.
Keywords: R01; clinician–scientist; physician–scientist.
Copyright 2020 The Authors.
Conflict of interest statement
Disclosure: E.A. Liu, None; S.Y. Wang, None; R.C. Rao, None
Figures
Comment in
-
The Clinician-Scientist in Vision Science: A Rare and Endangered Species.Transl Vis Sci Technol. 2020 Nov 25;9(12):33. doi: 10.1167/tvst.9.12.33. eCollection 2020 Nov. Transl Vis Sci Technol. 2020. PMID: 33262907 Free PMC article. No abstract available.
References
-
- Butler D. Translational research: crossing the valley of death. Nature. 2008; 453(7197): 840–842. - PubMed
-
- Roberts SF, Fischhoff MA, Sakowski SA, Feldman EL. Perspective: transforming science into medicine: how clinician-scientists can build bridges across research's “valley of death”. Acad Med. 2012; 87(3): 266–270. - PubMed
-
- Jain MK, Cheung VG, Utz PJ, Kobilka BK, Yamada T, Lefkowitz R. Saving the endangered physician-scientist - a plan for accelerating medical breakthroughs. N Engl J Med. 2019; 381(5): 399–402. - PubMed
-
- Wyngaarden JB. The clinical investigator as an endangered species. N Engl J Med. 1979; 301(23): 1254–1259. - PubMed
-
- Nathan DG. Careers in translational clinical research—historical perspectives, future challenges. JAMA. 2002; 287(18): 2424–2427. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
